On January 9, 2023 Bristol Myers Squibb (NYSE: BMY) reported that the company will present at J.P. Morgan’s 41st Annual Healthcare Conference on Monday, January 9, 2023 (Press release, Bristol-Myers Squibb, JAN 3, 2023, View Source [SID1234625724]). Giovanni Caforio, M.D., Board Chair and Chief Executive Officer will make a formal presentation and answer questions about the company at 7:30 a.m. PST/10:30 a.m. EST.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The event will be webcast simultaneously at View Source with materials related to the presentation available at the start of the live webcast. A replay and archived edition of the presentation will be available following the event.